The Hope of the Future in Myeloma Treatment with Dr. Sikander Ailawadhi image

The Hope of the Future in Myeloma Treatment with Dr. Sikander Ailawadhi

Aug 23, 2022
06:30PM - 08:00PM EDT
Online Event
Overview

The Florida Myeloma Community Chapter meets to discuss the hope for the future lives of patients and families affected by myeloma thanks to new and developing therapies. Dr. Ailawadhi is excited to hear patient and caregiver thoughts, questions and feelings on this subject. Do you have hope? What questions and concerns do you have about the future? We look forward to a great discussion together. 

Agenda
06:30 PM
Introduction
Audrey Burton-Bethke
Audrey introduces the agenda of the event and featured speaker Dr. Sikander Ailawadhi
06:35 PM
Presentation
Dr. Sikander Ailawadhi
Dr. Ailawadhi discusses the hope for the future lives of patients and families affected by myeloma thanks to new and developing therapies.
07:15 PM
Questions and Answers
Audience
Type your questions in the chat and we will answer them!
Speakers & Moderators
Healthtree contact Audrey Burton-Bethke

Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Healthtree contact Dr. Sikander Ailawadhi

Dr. Sikander Ailawadhi

Sikander Ailawadhi, MD, is a Professor of Medicine in the Division of Hematology/Oncology at the Mayo Clinic Florida located in Jacksonville, Florida. He is also the Lead for the International Cancer Center. Dr Ailawadhi's career focus includes the treatment of plasma cell disorders, multiple myeloma (MM), Waldenström's macroglobulinemia, and chronic lymphocytic leukemia (CLL). His research focuses on understanding the epidemiology and pathophysiology of these disorders; evaluating the benefit of various therapeutic strategies in different populations based on racial-ethnic and socioeconomic diversity; and developing novel therapeutics by means of conducting several regional and national clinical trials, such as clinical trials for novel drugs. Dr Ailawadhi has a special interest in understanding the disparities in care of cancer patients and their outcomes with a special focus on patients from different racial and ethnic backgrounds.